Skip to main content
. 2011 Mar 16;96(6):1737–1746. doi: 10.1210/jc.2010-2600

Fig. 2.

Fig. 2.

A–C, Immunohistochemistry of MIG6 in proliferative endometrium (A) and secretory endometrium from PCOS (B) and normal (C) subjects. D, HSCORE, as described in Patients and Methods, was used as a semiquantitative measure of tissue expression. Comparison by ANOVA revealed significant difference in MIG6 expression between normal and PCOS endometrium (P < 0.03).